Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer

Radiotherapy and Oncology

Volumn 58, Issue 1, 2001, Pages 83-87

  Lindel, Katja ^a   Willett, Christopher G ^a   Shellito, Paul C ^a   Ott, Mark J ^a   Clark, Jeffrey ^a   Grossbard, Michael ^a   Ryan, David ^a   Ancukiewicz, Marek ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Intraoperative radiation therapy; Local failure; Recurrent rectal carcinoma; Salvage

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CARCINOMA; SALVAGE THERAPY;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUOROURACIL; HUMANS; INTRAOPERATIVE CARE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; RECTAL NEOPLASMS; SALVAGE THERAPY; SIGMOID NEOPLASMS;

EID: 0035915780     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00309-1     Document Type: Article

References (25)

1. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer. Evidence in terms of response rate
2. Overview of clinical trials using 5-FU and leucovorin for the treatment of colorectal cancer
3. Radiotherapy treatment for isolated locoregional recurrence of rectosigmoid cancer following definitive surgery: Peter Maccallum Cancer Institute Experience, 1981-1990
4. Residual, unresectable, or recurrent colorectal cancer: External beam irradiation and intraoperative electron beam boost ± resection
5. Irradiation of adenocarcinomas of the gastrointestinal tract malignancies
6. Locally advanced primary and recurrent colorectal cancer. Disease control and survival with IOERT containing regimens
7. Locally advanced primary colorectal cancer: Intraoperative electron and external beam irradiation ± 5-FU
8. Areas of failure found at reoperation (second or symptomatic second look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy
9. Past, present, and future of intraoperative irradiation for colorectal cancer
10. Patterns of recurrent and metastatic carcinoma of colon and rectum treated with radiation
11. Nonparametric estimation for incomplete observations
12. Statistical aspects of the analysis of data from retrospective studies of disease
13. Combined 5-fluorouracil and supervoltage therapy for unresectable gastrointestinal cancer
14. Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features
15. Improved combined modality surgical adjuvant therapy for high risk rectal cancer
16. Dose-response relationship for radiation therapy of recurrent, residual and primary inoperable colorectal cancer
17. Effectiveness of local radiotherapy in colorectal carcinoma
18. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery
19. Long term survival and patterns of failure after postoperative radiation therapy for subtotally resected rectal adenocarcinoma
20. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer
21. Intraoperative radiation therapy for locally advanced rectal or rectosigmoid cancer
22. The role of radiation therapy in the management of carcinoma of the sigmoid, and rectum
23. Radiation therapy in the palliative management of patients with recurrent cancer of the rectum and colon
24. Intraoperative electron beam irradiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma
25. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03